S-EPMC9126560 - Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. - OmicsDI

Unknown

Dataset Information

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.

ABSTRACT:

SUBMITTER: Wolfe CR

PROVIDER: S-EPMC9126560 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature